FLT3 and myeloproliferative disorder: Previous studies performed with transgenic mice models expressing FLT3-ITD suggested that the expression of this receptor induced myeloproliferative neoplasms rather than AML, suggesting that FLT3-ITD expression by itself did not significantly affect the hematopoietic differentiation process in vivo [46].